Lorazepam Impurity 17 CAS CATO-C4X-104117
| CAS No. | CATO-C4X-104117 |
| Molecular Formula | C15H12Cl2N2O2 |
| Molecular Weight | 323.17 g/mol |
| Category | Pharmacopoeial Impurity Standards / EP Impurities |
| Availability | In Stock |
Chemical Structure
Description
CATO manufactures Lorazepam Impurity 17 under ISO 17034:2016 accreditation with dual CNAS and ANAB accreditation. Each batch is characterized by orthogonal methods and supplied with a full Certificate of Analysis (COA), ensuring metrological traceability.
Lorazepam Impurity 17 (CAS CATO-C4X-104117) is a certified pharmaceutical impurity reference standard with the molecular formula C15H12Cl2N2O2 and a molecular weight of 323.17 g/mol.
Lorazepam Impurity 17 (C15H12Cl2N2O2) contains a nitrogen-containing heterocyclic scaffold, an amide group, a hydroxyl group, an ether linkage, chlorine substitution. It is notably hygroscopic, halogen substitution raises its density and boiling point, its high carbon-to-hydrogen ratio confers good lipid solubility, the carboxyl group imparts weak acidity; these physicochemical properties determine the optimal preparation and storage of its standard solutions. Nitrogen-containing functional groups confer excellent ionization efficiency in positive-ion electrospray (ESI) mode, making the compound well suited to LC-MS/MS analysis.
This reference standard supports related-substances testing and method development in line with ICH Q3A/Q3B guidance on impurity control, and is suitable for system suitability testing and forced-degradation studies.
Physical & Chemical Properties
| Molecular Formula | C15H12Cl2N2O2 |
| Molecular Weight | 323.17 g/mol |
| Appearance | Pale yellow to yellow crystalline powder. (slight halide-like odor, low volatility) |
| Purity | 97%+ |
| Storage | Store at 2-8°C, protect from light, keep sealed and dry |
| Solubility (reference) | Soluble in DMSO, DMF, methanol |
| Stability | May oxidize slowly on prolonged air exposure; Light-sensitive; avoid direct strong light; Hygroscopic; reseal immediately after opening; Contains ester bond; hydrolyzes under strong alkaline conditions |
| Degree of Unsaturation (DBE) | 10.0 |
| UV Absorption | UV-absorbing |
| Structural Features | Aromatic ring present |
| Halogen Content | Cl-containing |
| Nitrogen Atoms | 2 |
Related Lorazepam Standards
Recommended Standards
- 2-Amino-N-(4-chloro-2-(2-chlorobenzoyl)phenyl)acetamide (CAS CATO-C3D-25936)
- Imatinib Impurity 99 (CAS 189037-78-3)
- 898759-61-0 (3,5-Dichlorophenyl)[3-(1,3-dioxolan-2-yl)phenyl]methanone DTXSID90645085 (CAS 898759-61-0)
- 4-Bromo-6-phenyldibenzo[b,d]furan (CAS 1010068-84-4)
- Nebivolol Impurity 45 (CAS 129050-26-6)
- Albendazole EP Impurity G (CAS 20367-38-8)
- Cariprazine Impurity 17 (CAS 1698050-40-6)
- 2-[(4-Cyano-5-methyl-1,2-thiazol-3-yl)sulfanyl]-N'-[2-(2,4-dichlorophenoxy)ethanimidoyl]acetohydrazide (CAS 338395-70-3)
- 3-(Trifluoromethoxy)piperidine hydrochloride (CAS 1310684-89-9)
- Finerenone Impurity 240 (CAS CATO-C4X-2880240)
- Benzothiazolium, 5-chloro-2-[2-[[5-chloro-3-(4-sulfobutyl)-2(3H)-benzothiazolylidene]methyl]-1-buten-1-yl]-3-(4-sulfobutyl)-, inner salt, compd. with N,N-diethylethanamine (CAS 63450-48-6)
- 4569AC 887267-77-8 C13H11F3N2O3S Ethyl 2-amino-4-(4-(trifluoromethoxy)phenyl)thiazole-5-carboxylate (CAS 887267-77-8)
- 4-tert-Butyl-5-(5,5-dimethyl-1,3-dioxan-2-yl)valerophenone (CAS 898755-70-9)
- CGMP Dependent Kinase Inhibitor Peptide (CAS 82801-73-8)
Why CATO?
- ISO 17034 accredited reference material producer (CNAS + ANAB dual accreditation)
- 130,000+ catalog items in stock, COA supplied with every batch
- Worldwide shipping with full export documentation (HS code guidance available)
- Technical support: +86 18665070610 / Nicole.chen@cato-chem.com